Swil-NewsFRI · NOV 20 · 2026 · ISSUE № 2026.11.20
Same-day topicsGeneralFinance & marketsAI & techScience & researchCrypto & Web3Energy & climateAuto & mobilityGaming & entertainmentSupply chain & manufacturingSports, health & nutritionCurrent
Back to Sports, health & nutritionBack to home

Nov 20, 2026 · Sports, Health & Nutrition Daily Digest

A roundup of today's exercise, health and nutrition science news, compiled on November 20, 2026, with summaries, links and commentary.


I. Nutrition & Diet

1. WashU RCT: with matched weight loss, a ketogenic diet cut liver fat more (Nutrition)

Summary:

A Cell Metabolism randomized trial enrolled 55 adults with obesity, prediabetes and fatty liver; 42 completed analysis after assignment to a ketogenic, Mediterranean or very-low-fat plant-forward diet with all meals provided. Groups lost about 10% of body weight over roughly 4–5 months. Muscle insulin sensitivity rose about 50% in all arms, but intrahepatic triglyceride fell 67% on keto versus about 45% on the other diets; about half of the keto group no longer met prediabetes criteria, versus about 29% on Mediterranean and 7% on low-fat. Despite ~73% of calories from fat, keto did not raise LDL-C, ApoB or 24-hour triglycerides relative to the others during the trial.

Links:

Commentary:

This was a small, short, tightly controlled feeding RCT, so it supports carbohydrate restriction for people with fatty liver plus prediabetes beyond matched weight loss—not a mandate that everyone go keto, given adherence and individual medical constraints.


2. Crossover feeding trial: a whole-food plant-based diet lowered LDL-C ~18% in familial hypercholesterolemia (Nutrition)

Summary:

A Nature Communications randomized crossover, fully controlled feeding trial in 50 adults with genetically confirmed heterozygous familial hypercholesterolemia compared four weeks of a whole-food plant-based diet (WFPB) with a standard American diet (SAD) off lipid-lowering drugs. Versus SAD, WFPB cut LDL-C by 17.9% (~1.28 mmol/L), improved ApoB and related atherogenic markers by over 14%, lowered blood pressure by about 2 mm Hg, and reduced estimated 10-year CVD risk by about 11.9%. Responses varied: ~10% saw ≥30% LDL-C drops, and ~10% saw rises.

Links:

Commentary:

Even with genetic high cholesterol, cutting saturated fat and raising unsaturated fat and fiber can move lipids meaningfully, but diet does not replace prescribed lipid therapy—do not stop medication on your own.


3. Sydney RCT: when starting metformin, a personalized glucose diet did not beat a standard low-fat high-fiber diet (Evidence)

Summary:

A Communications Medicine randomized trial assigned 151 adults with prediabetes or early type 2 diabetes to a personalized postprandial-glucose diet (PPT) or a standard low-fat, high-fiber diet (SOC) while starting metformin 1.5 g/day; 138 entered intention-to-treat analysis. At six months, HbA1c fell in both arms with no between-diet difference; weight, body composition, liver fat and cardiometabolic markers improved similarly, with slightly better glycemic variability on PPT. Exploratory microbiome measures declined even as metabolism improved.

Links:

Commentary:

With medication on board, algorithmic personalization may not outpace a solid healthy diet; for most people, locking in low-fat, high-fiber, minimally processed eating beats chasing a glucose app.


II. Exercise & Training Science

4. Nature Medicine RCT: thrice-weekly resistance training blunts lean-tissue loss on tirzepatide (Training)

Summary:

In a two-arm Australian RCT, 120 adults with overweight or obesity on tirzepatide were randomized to thrice-weekly resistance exercise or usual activity for 40 weeks; resistance adherence was about 91%. Weight loss was similar (~−22.3 to −22.6 kg) and fat-mass loss comparable, but resistance training reduced total lean soft-tissue loss (−3.57 kg vs −4.67 kg; between-group difference ~1.09 kg) and appendicular lean loss; bench press, lat pulldown and knee-extension strength fell with drug alone and rose with training. Nature highlighted the trial on November 20.

Links:

Commentary:

If you use a GLP-1 or dual agonist for weight loss, treat resistance training as standard care to protect muscle and strength—not just the number on the scale.


5. "Exercise snacks" RCT: the same walking dose steadies glucose better when split across the day (Training)

Summary:

An ACTIMOVE trial from CU Anschutz and CNRS, published in Obesity, randomized 30 sedentary adults aged 18–45 with overweight/obesity to six weeks of 45 minutes of brisk walking five days a week, either as one bout (ONE) or as roughly five-minute walks each hour (BREAK). Total activity and energy expenditure changed similarly; only BREAK cut prolonged sitting. Insulin sensitivity did not improve in either arm, but BREAK showed more favorable IVGTT glucose AUC, time-in-range and glycemic variability on continuous monitoring.

Links:

Commentary:

In this small short trial, how you accumulate movement mattered: office workers can prioritize hourly short walks to break sitting rather than insisting on one unbroken 45-minute session.


6. Finnish yearlong program: nearly half of adults over 70 improved across several physical-function measures, with wide individual variation (Training)

Summary:

University of Jyväskylä researchers followed 314 adults over age 70 through a 12-month multicomponent exercise program, published in the European Journal of Applied Physiology. At the group level, strength, walking speed and endurance improved, with no overall muscle-mass change; individual responses varied widely. When multiple outcomes were considered together, nearly half achieved meaningful gains across several domains; younger age within the cohort, lower BMI, better strength-training adherence, or multimorbidity predicted multi-outcome success.

Links:

Commentary:

Do not judge older adults' training by muscle mass or grip alone; chronic disease is not a reason to skip exercise, and sticking with strength work often matters more than finding a perfect program.


III. Public Health & Guidelines

7. WHO issues first adult type 1 diabetes guideline: multiple daily insulin injections and accessible glucose monitoring (Guidelines)

Summary:

Marking World Diabetes Day 2026, WHO released its first guideline on diagnosis and management of type 1 diabetes in adults, including low-resource, emergency and humanitarian settings. It strongly recommends intensified insulin therapy with multiple daily injections adjusted to blood glucose; human insulin and analogues are both acceptable, with human insulin preferred for lower cost; regular monitoring (clinic HbA1c, fingerstick or CGM; urine glucose when blood testing is unavailable) is emphasized. A companion pediatric/adolescent guideline was also issued.

Links:

Commentary:

The public takeaway is access: insulin and monitoring save lives; for patients, the core remains regular dosing adjusted to glucose—not chasing the newest analogue by default.


8. Oxford modelling in 5.5 million records: blood-pressure drugs prevent more heart attacks/strokes than they cause serious falls (Public health)

Summary:

Nature Communications published on November 20 a modelling study using English electronic health records from about 5.578 million patients aged ≥40. Treating 1,000 people for 10 years was estimated to prevent about eight serious cardiovascular events while causing about two serious falls; absolute CVD benefit still outweighed serious falls even in older men with moderate frailty (e.g., ~47 vs 9 per 1,000). Syncope and acute kidney injury were more finely balanced; hypotension and hyperkalaemia could outnumber CVD events prevented but are generally less severe.

Links:

Commentary:

Fear of falls is not a blanket reason to stop antihypertensives; discuss individual risk with a clinician and add fall prevention (slow standing, calcium/vitamin D as indicated, home safety) rather than abandoning blood-pressure control.


IV. Sleep & Mental Health

9. All of Us + Fitbit cohort: night-to-night sleep irregularity—not mean duration—tracked with cardiovascular events (Sleep)

Summary:

Circulation: Population Health and Outcomes analyzed 10,362 US All of Us adults with linked Fitbit and EHR data and no baseline cardiometabolic disease, using ~180 days of sleep metrics. Each 1-SD (~29-minute) rise in night-to-night sleep-duration variability was associated with ~24% higher risk of a CVD composite (MI, heart failure, cardiomyopathy or ischemic stroke); irregular bedtime, wake time and midpoint raised risk ~20–23%; mean sleep duration was not associated with the composite. More wearable-estimated sleep cycles were linked to lower atrial-arrhythmia risk in exploratory analyses.

Links:

Commentary:

Observational links are not proof of causation, but the actionable lever is clear: when total hours are hard to control, lock bedtime and wake time and shrink weekday–weekend catch-up swings.


10. TemPredict ~23,000 adults: lower sleep regularity tracked with worse depression, anxiety and loneliness (Sleep/Mental health)

Summary:

A UCSF/UCSD analysis in Scientific Reports from the TemPredict cohort (N≈22,894; smart-ring sleep for ~154 days on average) found graded associations between lower Sleep Regularity Index (SRI) and worse depression, anxiety and loneliness: mean SRI was about 83.74 with minimal depression symptoms versus 74.93 with severe depression, and about 78.94 with severe anxiety versus 83.67 within normal limits. Each 5-point SRI drop raised odds of worse symptom strata; authors stress the design cannot establish directionality—symptoms may also disrupt schedules.

Links:

Commentary:

Echoing the heart findings, schedule regularity is a controllable lever; moderate-to-severe mood symptoms still need clinical care, not schedule tweaks alone.


V. Sports Medicine & Evidence Clarification

11. Meta-analysis: neuromuscular training may cut athletes' lower-limb injury risk ~28%, with very low certainty (Sports medicine)

Summary:

A Sports Medicine - Open systematic review and meta-analysis pooled 27 RCTs (~27,663 participants). Neuromuscular training (NMT) was associated with lower lower-limb injury risk (RR≈0.72); structured and multidimensional programmes showed favourable subgroup estimates, as did adolescent and football/basketball settings in exploratory cuts. Dose-level signals favoured roughly 2–3 sessions/week, 16–25 minutes/session, over 1.5–12 months, but GRADE certainty was very low and authors warn against treating dose findings as a causal optimum.

Links:

Commentary:

Recreational runners and team-sport players can still add balance, landing control and strength to warm-ups, but treat "28% fewer injuries" as uncertain—and adherence as the real bottleneck.


12. Systematic review: oral N-acetylcysteine (NAC) has a reasonable expectation of safety as a dietary supplement (Evidence)

Summary:

Toxicological Sciences published on November 16 an FDA-related systematic safety review that screened 149 studies and retained 41 high-quality ones. Aside from one ulcerative-colitis trial with more nausea at 800 mg/day for 16 weeks, remaining high-quality studies did not show corresponding AE increases at doses up to about 9,000 mg/day for as long as about three years; clinical exposures overlapped marketed supplement servings. The review concludes a reasonable expectation of safety for NAC as a dietary supplement, while noting its special US regulatory status due to prior drug approval.

Links:

Commentary:

"Reasonably safe" is not the same as "worth taking"; without a clear medical indication, this review is not a reason to stock NAC, and people with liver/kidney disease or polypharmacy should ask a clinician first.


Today's Summary

  • With matched weight loss, keto showed larger liver-fat and prediabetes gains; a plant-based diet still moved LDL-C ~18% in genetic high cholesterol—but does not replace drugs.
  • In the obesity-drug era, resistance training is the muscle-preserving default; "exercise snacks" that break sitting may steady glucose better than one long walk at the same dose.
  • Sleep science again highlights regularity: night-to-night schedule swings tracked with cardiovascular and mood signals more than average duration alone.

Daily Framing:

Today in the sports/health/nutrition cycle was a "pair metabolic interventions with training and sleep regularity" day—diet macros and weight-loss drugs work, but resistance work, fragmented movement and consistent sleep decide whether you keep muscle and glucose control or just a smaller scale number.


This digest is compiled from real-time search results and is for reference only.

MORE FROM SPORTS, HEALTH & NUTRITION

Nov 21, 2026

Nov 21, 2026 · Sports, Health & Nutrition Daily Digest

A roundup of today's exercise, health and nutrition science news, compiled on November 21, 2026, with summaries, links and commentary.
Nov 17, 2026

Nov 17, 2026 · Sports, Health & Nutrition Daily Digest

A roundup of today's exercise, health and nutrition science news, compiled on November 17, 2026, with summaries, links and commentary.
Nov 16, 2026

Nov 16, 2026 · Sports, Health & Nutrition Daily Digest

Compiled on Nov 16, 2026: today's notable fitness, health and nutrition news, with summaries, links and commentary.